Tiva Biosciences is pleased to launch off-the-shelf products to accelerate targeted-LNP development
Tiva Biosciences reporter mRNA materials are manufactured and tested under GMP compliant conditions. These reporter mRNAs have been used extensively in both in vitro and in vivo experiments
Reporter mRNA Materials
Manufactured and tested under GMP compliant conditions. These reporter mRNAs have been used extensively in both in vitro and in vivo experiments.
| Description | Cat # | Key Applications | Purity | Integrity | Residual dsRNA | Endotoxin |
|---|---|---|---|---|---|---|
| eGFP mRNA | 10001-10mg | Reporter | ≥96% | ≥90% | <0.01% | <0.01 EU/mg |
Targeted LNP Formulations
Shows a high percentage of conjugated LNP and a high degree of CD8-cell-specific transfection.
| Description | Cat # | Key Applications | Size | PDI | Encapsulation % | Conjugation % |
|---|---|---|---|---|---|---|
| CD8-eGFP-LNP | 20001-1mg | Ref standard | <100nm | <0.15 | >90% | >80% |
| CD3-eGFP-LNP | 20002-1mg | Ref standard | <100nm | <0.15 | >90% | >80% |
Tiva Biosciences CD8-eGFP-LNP shows high percentage of conjugated LNP, and high degree of CD8-cell- specific transfection
